Data from Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer

MLA

Charles L. Sentman, et al. Data from Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.c.6495947.v1.

APA

Charles L. Sentman, Katherine F. Roby, Jose Conejo-Garcia, Leslie R. DeMars, Tong Zhang, & Amorette Barber. (2023). Data from Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer. https://doi.org/10.1158/0008-5472.c.6495947.v1

Chicago

Charles L. Sentman, Katherine F. Roby, Jose Conejo-Garcia, Leslie R. DeMars, Tong Zhang, and Amorette Barber. 2023. “Data from Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer,” March. doi:10.1158/0008-5472.c.6495947.v1.